/

Società

AM

Società

AMSBIOPHARMA

Di cosa scriviamo

Auto/AutomotiveFarmaciaSaluteSanitàUniversità

28 comunicati stampa

Guarda tutti i comunicati

Press Release cover image

18/12/2025

Salute

Sanità

UPLC-MS/MS method development for peptide analysis | AMSbiopharma

Fonte

1.00

0

Press Release cover image

11/12/2025

Salute

Sanità

Stability-indicating methods for peptide drug analysis | AMSbiopharma

Fonte

1.00

0

Press Release cover image

26/11/2025

Salute

Sanità

Accelerate Drug Development with Preclinical Contract Research | AMSbiopharma

Fonte

1.00

0

Press Release cover image

19/11/2025

Università

Salute

Sanità

Optimize LC‑MS/MS Sensitivity: Ion Suppression in Bioanalysis | AMSbiopharma

Fonte

1.00

0

Press Release cover image

29/10/2025

Salute

Sanità

Biomarkers for Bioanalytical Research in Drug Development | AMSbiopharma

Fonte

1.00

0

Press Release cover image

21/10/2025

Università

Salute

Sanità

How Mass Spectrometry enhances GMP quality control with LC‑MS | AMSbiopharma

Fonte

1.00

0

Press Release cover image

30/09/2025

Salute

Giochi

Ingegneria

AMSbiopharma completes its Innovation Plan, supported by Innova Pyme, achieving progress in services, technology, and entrepreneurial culture | AMSbiopharma

Fonte

1.00

0

Press Release cover image

22/09/2025

Salute

Sanità

Impurity profiling and HPLC methods for drug quality compliance | AMSbiopharma

Fonte

1.00

0

Press Release cover image

25/08/2025

Salute

Sanità

Pharma Quality Control in Drug Development and Compliance | AMSbiopharma

Fonte

1.00

0

Press Release cover image

11/08/2025

Salute

Sanità

Preclinical research strategies for drug development | AMSbiopharma

Fonte

1.00

0

Seguaci

0

Compatibilità

0